Dokumentumok
KPS PONT
Label: inflammatory bowel disease
FDA: Cancer Warnings Required for TNF Blockers
The U.S. Food and Drug Administration is requiring stronger warnings in the prescribing information for a class of drugs known as TNF blockers. The warnings, which include an updated boxed warning, highlight the increased risk of cancer More»
Cancer Risk from Inflammatory Bowel Disease
Incidence of colorectal cancer did not change over time, although risk for CRC-related mortality declined. Background & Aims: Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). There have More»
Inflammatory Bowel Disorders
Under construction More»
